~~<i id='C723A05457'><strike id='C723A05457'><tt id='C723A05457'><pre id='C723A05457'></pre></tt></strike></i>~~

Home» leisure time» explore

explore

author：leisure time 2025-09-27 19:17:35 Page View：51388

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hospitals warn Medicare's drug payment fix is ‘unlawful’
Next article： Psychedelics group wrestles with new pharma identity

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

FILE-U.SsoccerplayerMeganRapinoespeakstoreportersduringthe2023Women'sWorldCupmediadayfortheUnitedSta

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

FILE-U.SsoccerplayerMeganRapinoespeakstoreportersduringthe2023Women'sWorldCupmediadayfortheUnitedSta